Title | Blue-green spectral minimum correlates with oxyhemoglobin saturation in vivo. |
Publication Type | Journal Article |
Year of Publication | 2008 |
Authors | Denninghoff KR, Salyer DA, Basavanthappa S, Park RI, Chipman RA |
Journal | J Biomed Opt |
Volume | 13 |
Issue | 5 |
Pagination | 054059 |
Date Published | 2008 Sep-Oct |
ISSN Number | 1083-3668 |
Keywords | Animals, Fluorescein Angiography, Lighting, Microscopy, Fluorescence, Oximetry, Oxyhemoglobins, Retinal Artery, Retinoscopy, Statistics as Topic, Swine |
Abstract | An imaging multi-spectral retinal oximeter with intravitrial illumination is used to perform the first in vivo test of the blue-green minima shift oximetry method (BGO) in swine eyes [K. R. Dennighoff, R. A. Chipman, and L. W. Hillman, Opt. Lett. 31, 924-926 (2006); J. Biomed. Opt. 12, 034020 (2007).] A fiber optic intravitreal illuminator inserted through the pars plana was coupled to a monochromator and used to illuminate the retina from an angle. A camera viewing through the cornea recorded a series of images at each wavelength. This intravitreal light source moves the specular vessel glint away from the center of the vessel and directly illuminates the fundus behind most blood vessels. These two conditions combine to provide accurate measurements of vessel and perivascular reflectance. Equations describing these different light paths are solved, and BGO is used to evaluate large retinal vessels. In order to test BGO calibration in vivo, data were acquired from swine with varied retinal arterial oxyhemoglobin saturations (60-100% saturation.). The arterial saturations determined using BGO to analyze the multispectral image sets showed excellent correlation with co-oximeter data (r2=0.98, and residual error +/-3.4% saturation) and are similar to results when hemoglobin and blood were analyzed using this technique. |
DOI | 10.1117/1.3005390 |
Alternate Journal | J Biomed Opt |
PubMed ID | 19021438 |
Blue-green spectral minimum correlates with oxyhemoglobin saturation in vivo.
Faculty Reference:
Kurt Denninghoff, MD